Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Inspired by biological systems, materials scientists have long sought to harness self-assembly to build nanomaterials. The challenge: the process seemed random and notoriously difficult to predict.

At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the ...

Survivors of Abuse NJ has announced an expanded initiative to raise awareness of civil legal remedies available to ...

Looking back on therapeutics stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Novavax ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

As people grow older, their immune systems do not simply slow down, they often become locked into a simmering, ...

As the year comes to an end, Envelope editor in chief Matt Brennan runs down his top movies and TV shows of 2025.

For all of the political chaos that American science endured in 2025, aspects of this country’s research enterprise made it ...